Topics:

COPD

Drug Offers Novel Approach for Airway Diseases

For patients with asthma or COPD, PL554 has the potential to both reverse bronchodilation and reduce inflammation more quickly and with fewer adverse effects.
 

COPD

A new study shows that the risk of chronic obstructive pulmonary disease increases with obesity. Yet, the risk was increased in underweight persons as well.

For patients with asthma or COPD, PL554 has the potential to both reverse bronchodilation and reduce inflammation more quickly and with fewer adverse effects.

Patients respond to 5 days of corticosteroid therapy just as well as to 14 days of therapy, according to a study.

Emphysematous cholecystitis is a rare condition that is the result of infection with Clostridium perfringens and other gas-producing organisms including Escherichia coli, Bacteroides fragilis, and Klebsiella species.

Older patients with chronic obstructive pulmonary disease are at higher risk for plaque formation in the carotid artery, increasing their risk of stroke.

Diagnoses of chronic obstructive pulmonary disease may increase with the use of a 5-question patient-administered survey.

Patients with COPD are often reluctant to talk about the negative impact of the disease on their lives. But these unspoken concerns may become barriers to effective management. It is up to you to ask the appropriate, often difficult questions. Here, 5 examples of things your patients with COPD might not be telling you—and why you need to know.

Pages

Subscribe to COPD on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.